23-Sep-16 Merck’s immunotherapy cancer drug Keytruda is finding its way into China as the first imported drug approved for use under a pilot program on the resort island of Hainan intended to boost medical tourism. The zone in Boao is likely to attract patients who would otherwise travel to Hong Kong or Macau for drugs yet to be approved in China. [image: Anthony Wallace / AFP / Getty Images]

19-Sep-16 With China's demographic shifting towards an ever-higher ratio of citizens aged 60-plus, elder-friendly wearables are seen as a key means of monitoring the health and whereabouts of this affluent, yet vulnerable, sector of contemporary society. In the elderly sector, wearables tend to be either tracking devices or fall alarms. [image: HKTDC Research]

11-Sep-16 While demographers still assess the effects of the relaxation of the one-child policy, pregnant women and hospitals are feeling the squeeze. China forecasts that an extra 17 mn babies will be born within the next five years. In some of those years, there are expected to be more than 20 mn births. [image: South China Morning Post]

10-Sep-16 Studies in Taiwan and China have shown reductions in incident myopia of 25-50% when children spend an additional 40-80 minutes outdoors. In Taiwan, two hours of outdoor activity has been added to school programs. “Evidence that children who spend more time outdoors... are less likely to be or become myopic has been presented,” said Nina Jacobsen MD. [image: Zeiss]

31-Aug-16  Japanese ophthalmology specialist Santen Pharmaceutical has announced the start of operations of its joint venture with state-owned Chinese group Chongqing Kerui. This partnership, which will involve the establishment of China’s largest manufacturing site for eye care treatments in the city of Chongqing, promises to provide people in China with affordable ophthalmic products. [image: Santen Pharmaceutical]